nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—osteoporosis	0.738	1	CbGaD
Pemetrexed—Tetrahydrofolic acid—ATIC—osteoporosis	0.00226	0.434	CrCbGaD
Pemetrexed—Methotrexate—ATIC—osteoporosis	0.00154	0.297	CrCbGaD
Pemetrexed—ATIC—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000605	0.194	CbGdCrCtD
Pemetrexed—Tetrahydrofolic acid—MTHFR—osteoporosis	0.000522	0.1	CrCbGaD
Pemetrexed—Folic Acid—MTHFR—osteoporosis	0.000522	0.1	CrCbGaD
Pemetrexed—DCK—Fulvestrant—Estradiol—osteoporosis	0.000514	0.165	CbGdCrCtD
Pemetrexed—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.000481	0.154	CbGdCrCtD
Pemetrexed—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.00047	0.151	CbGdCrCtD
Pemetrexed—Methotrexate—MTHFR—osteoporosis	0.000357	0.0686	CrCbGaD
Pemetrexed—DCK—Levorphanol—Estradiol—osteoporosis	0.000339	0.109	CbGdCrCtD
Pemetrexed—DHFR—G1/S Transition—PSMA2—osteoporosis	0.000277	0.00259	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—PSMA5—osteoporosis	0.000277	0.00259	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—GPX1—osteoporosis	0.000274	0.00256	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ATIC—osteoporosis	0.000265	0.00248	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PNP—osteoporosis	0.000265	0.00248	CbGpPWpGaD
Pemetrexed—TYMS—Levorphanol—Estradiol—osteoporosis	0.000256	0.082	CbGdCrCtD
Pemetrexed—DHFR—Folate Metabolism—MTHFR—osteoporosis	0.000252	0.00236	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—PSMA5—osteoporosis	0.000242	0.00226	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—PSMA2—osteoporosis	0.000242	0.00226	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000234	0.00218	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000234	0.00218	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000232	0.00217	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CA2—osteoporosis	0.000225	0.00211	CbGpPWpGaD
Pemetrexed—GART—Metabolism—OXCT1—osteoporosis	0.000225	0.00211	CbGpPWpGaD
Pemetrexed—GART—Metabolism—MGLL—osteoporosis	0.00022	0.00205	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—FDPS—osteoporosis	0.000212	0.00198	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PKM—osteoporosis	0.000212	0.00198	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.000209	0.00195	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000204	0.00191	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000204	0.00191	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—osteoporosis	0.000203	0.0019	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000202	0.00189	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PGLS—osteoporosis	0.000201	0.00188	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GPD2—osteoporosis	0.000201	0.00188	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SOST—osteoporosis	0.000197	0.00184	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PKM—osteoporosis	0.000197	0.00184	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000194	0.00181	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ANTXR2—osteoporosis	0.000187	0.00175	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PGLS—osteoporosis	0.000187	0.00175	CbGpPWpGaD
Pemetrexed—GART—Metabolism—IDH2—osteoporosis	0.000187	0.00175	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PNP—osteoporosis	0.000184	0.00172	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000184	0.00172	CbGpPWpGaD
Pemetrexed—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000177	0.0012	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Raloxifene—osteoporosis	0.000177	0.0012	CcSEcCtD
Pemetrexed—Diarrhoea—Etidronic acid—osteoporosis	0.000177	0.0012	CcSEcCtD
Pemetrexed—Abdominal pain—Estropipate—osteoporosis	0.000177	0.0012	CcSEcCtD
Pemetrexed—Body temperature increased—Estropipate—osteoporosis	0.000177	0.0012	CcSEcCtD
Pemetrexed—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000176	0.0012	CcSEcCtD
Pemetrexed—GART—Metabolism—CYP27A1—osteoporosis	0.000176	0.00164	CbGpPWpGaD
Pemetrexed—Infection—Risedronate—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Estradiol—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Ibandronate—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Arthralgia—Pamidronate—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Myalgia—Pamidronate—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Urticaria—Alendronate—osteoporosis	0.000175	0.00119	CcSEcCtD
Pemetrexed—Body temperature increased—Alendronate—osteoporosis	0.000174	0.00118	CcSEcCtD
Pemetrexed—Abdominal pain—Alendronate—osteoporosis	0.000174	0.00118	CcSEcCtD
Pemetrexed—Shock—Risedronate—osteoporosis	0.000174	0.00118	CcSEcCtD
Pemetrexed—Anaemia—Zoledronate—osteoporosis	0.000174	0.00118	CcSEcCtD
Pemetrexed—Nervous system disorder—Risedronate—osteoporosis	0.000173	0.00118	CcSEcCtD
Pemetrexed—Skin disorder—Risedronate—osteoporosis	0.000171	0.00117	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Calcitriol—osteoporosis	0.000171	0.00117	CcSEcCtD
Pemetrexed—Abdominal pain—Raloxifene—osteoporosis	0.000171	0.00116	CcSEcCtD
Pemetrexed—Body temperature increased—Raloxifene—osteoporosis	0.000171	0.00116	CcSEcCtD
Pemetrexed—GART—Metabolism—ACP5—osteoporosis	0.000171	0.0016	CbGpPWpGaD
Pemetrexed—Urticaria—Ibandronate—osteoporosis	0.00017	0.00116	CcSEcCtD
Pemetrexed—Body temperature increased—Ibandronate—osteoporosis	0.000169	0.00115	CcSEcCtD
Pemetrexed—Abdominal pain—Ibandronate—osteoporosis	0.000169	0.00115	CcSEcCtD
Pemetrexed—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.000169	0.0542	CbGdCrCtD
Pemetrexed—Syncope—Zoledronate—osteoporosis	0.000168	0.00115	CcSEcCtD
Pemetrexed—Leukopenia—Zoledronate—osteoporosis	0.000168	0.00114	CcSEcCtD
Pemetrexed—Oedema—Pamidronate—osteoporosis	0.000168	0.00114	CcSEcCtD
Pemetrexed—Anaphylactic shock—Pamidronate—osteoporosis	0.000168	0.00114	CcSEcCtD
Pemetrexed—Infection—Pamidronate—osteoporosis	0.000167	0.00113	CcSEcCtD
Pemetrexed—Urticaria—Calcitriol—osteoporosis	0.000167	0.00113	CcSEcCtD
Pemetrexed—Hepatitis—Estradiol—osteoporosis	0.000166	0.00113	CcSEcCtD
Pemetrexed—Body temperature increased—Calcitriol—osteoporosis	0.000166	0.00113	CcSEcCtD
Pemetrexed—Abdominal pain—Calcitriol—osteoporosis	0.000166	0.00113	CcSEcCtD
Pemetrexed—Shock—Pamidronate—osteoporosis	0.000165	0.00112	CcSEcCtD
Pemetrexed—Loss of consciousness—Zoledronate—osteoporosis	0.000165	0.00112	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—FDPS—osteoporosis	0.000165	0.00154	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PKM—osteoporosis	0.000165	0.00154	CbGpPWpGaD
Pemetrexed—Pharyngitis—Estradiol—osteoporosis	0.000165	0.00112	CcSEcCtD
Pemetrexed—Hypersensitivity—Estropipate—osteoporosis	0.000165	0.00112	CcSEcCtD
Pemetrexed—Nervous system disorder—Pamidronate—osteoporosis	0.000165	0.00112	CcSEcCtD
Pemetrexed—Thrombocytopenia—Pamidronate—osteoporosis	0.000164	0.00112	CcSEcCtD
Pemetrexed—Urinary tract disorder—Estradiol—osteoporosis	0.000164	0.00112	CcSEcCtD
Pemetrexed—Vomiting—Etidronic acid—osteoporosis	0.000164	0.00112	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL6—osteoporosis	0.000164	0.00153	CbGpPWpGaD
Pemetrexed—Urethral disorder—Estradiol—osteoporosis	0.000163	0.00111	CcSEcCtD
Pemetrexed—Rash—Etidronic acid—osteoporosis	0.000163	0.00111	CcSEcCtD
Pemetrexed—Dermatitis—Etidronic acid—osteoporosis	0.000163	0.00111	CcSEcCtD
Pemetrexed—Syncope—Conjugated Estrogens—osteoporosis	0.000162	0.0011	CcSEcCtD
Pemetrexed—Hypertension—Zoledronate—osteoporosis	0.000162	0.0011	CcSEcCtD
Pemetrexed—Hypersensitivity—Alendronate—osteoporosis	0.000162	0.0011	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000161	0.00109	CcSEcCtD
Pemetrexed—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000161	0.0516	CbGdCrCtD
Pemetrexed—Asthenia—Estropipate—osteoporosis	0.00016	0.00109	CcSEcCtD
Pemetrexed—Anorexia—Pamidronate—osteoporosis	0.00016	0.00109	CcSEcCtD
Pemetrexed—Myalgia—Zoledronate—osteoporosis	0.00016	0.00109	CcSEcCtD
Pemetrexed—Chest pain—Zoledronate—osteoporosis	0.00016	0.00109	CcSEcCtD
Pemetrexed—Arthralgia—Zoledronate—osteoporosis	0.00016	0.00109	CcSEcCtD
Pemetrexed—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000159	0.00108	CcSEcCtD
Pemetrexed—SLC46A1—Disease—GSN—osteoporosis	0.000159	0.00149	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000159	0.00108	CcSEcCtD
Pemetrexed—GART—Metabolism—TPI1—osteoporosis	0.000159	0.00148	CbGpPWpGaD
Pemetrexed—Pruritus—Estropipate—osteoporosis	0.000158	0.00107	CcSEcCtD
Pemetrexed—Asthenia—Alendronate—osteoporosis	0.000158	0.00107	CcSEcCtD
Pemetrexed—Hypersensitivity—Ibandronate—osteoporosis	0.000158	0.00107	CcSEcCtD
Pemetrexed—Dyspnoea—Risedronate—osteoporosis	0.000157	0.00107	CcSEcCtD
Pemetrexed—Erythema multiforme—Estradiol—osteoporosis	0.000157	0.00107	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—GPD2—osteoporosis	0.000156	0.00146	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PGLS—osteoporosis	0.000156	0.00146	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000156	0.00106	CcSEcCtD
Pemetrexed—ATIC—Metabolism—OXCT1—osteoporosis	0.000156	0.00146	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CA2—osteoporosis	0.000156	0.00146	CbGpPWpGaD
Pemetrexed—Fatigue—Ethinyl Estradiol—osteoporosis	0.000156	0.00106	CcSEcCtD
Pemetrexed—Pruritus—Alendronate—osteoporosis	0.000156	0.00106	CcSEcCtD
Pemetrexed—Dyspepsia—Risedronate—osteoporosis	0.000155	0.00106	CcSEcCtD
Pemetrexed—Eye disorder—Estradiol—osteoporosis	0.000155	0.00106	CcSEcCtD
Pemetrexed—Constipation—Ethinyl Estradiol—osteoporosis	0.000155	0.00105	CcSEcCtD
Pemetrexed—Hypersensitivity—Calcitriol—osteoporosis	0.000154	0.00105	CcSEcCtD
Pemetrexed—Arthralgia—Conjugated Estrogens—osteoporosis	0.000154	0.00105	CcSEcCtD
Pemetrexed—Chest pain—Conjugated Estrogens—osteoporosis	0.000154	0.00105	CcSEcCtD
Pemetrexed—Myalgia—Conjugated Estrogens—osteoporosis	0.000154	0.00105	CcSEcCtD
Pemetrexed—Asthenia—Ibandronate—osteoporosis	0.000154	0.00105	CcSEcCtD
Pemetrexed—Nausea—Etidronic acid—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Anaphylactic shock—Zoledronate—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Oedema—Zoledronate—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Diarrhoea—Estropipate—osteoporosis	0.000153	0.00104	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Risedronate—osteoporosis	0.000152	0.00104	CcSEcCtD
Pemetrexed—Infection—Zoledronate—osteoporosis	0.000152	0.00104	CcSEcCtD
Pemetrexed—ATIC—Metabolism—MGLL—osteoporosis	0.000152	0.00142	CbGpPWpGaD
Pemetrexed—Fatigue—Risedronate—osteoporosis	0.000152	0.00104	CcSEcCtD
Pemetrexed—Pruritus—Ibandronate—osteoporosis	0.000152	0.00103	CcSEcCtD
Pemetrexed—Pain—Risedronate—osteoporosis	0.000151	0.00103	CcSEcCtD
Pemetrexed—Constipation—Risedronate—osteoporosis	0.000151	0.00103	CcSEcCtD
Pemetrexed—Shock—Zoledronate—osteoporosis	0.000151	0.00103	CcSEcCtD
Pemetrexed—Diarrhoea—Alendronate—osteoporosis	0.000151	0.00102	CcSEcCtD
Pemetrexed—Asthenia—Calcitriol—osteoporosis	0.00015	0.00102	CcSEcCtD
Pemetrexed—Nervous system disorder—Zoledronate—osteoporosis	0.00015	0.00102	CcSEcCtD
Pemetrexed—Thrombocytopenia—Zoledronate—osteoporosis	0.00015	0.00102	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL1B—osteoporosis	0.00015	0.0014	CbGpPWpGaD
Pemetrexed—Dyspnoea—Pamidronate—osteoporosis	0.00015	0.00102	CcSEcCtD
Pemetrexed—GART—Metabolism—P4HB—osteoporosis	0.000149	0.0014	CbGpPWpGaD
Pemetrexed—Skin disorder—Zoledronate—osteoporosis	0.000149	0.00101	CcSEcCtD
Pemetrexed—Pruritus—Calcitriol—osteoporosis	0.000148	0.00101	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000148	0.00101	CcSEcCtD
Pemetrexed—Diarrhoea—Raloxifene—osteoporosis	0.000148	0.00101	CcSEcCtD
Pemetrexed—Dyspepsia—Pamidronate—osteoporosis	0.000148	0.001	CcSEcCtD
Pemetrexed—Dizziness—Estropipate—osteoporosis	0.000148	0.001	CcSEcCtD
Pemetrexed—Oedema—Conjugated Estrogens—osteoporosis	0.000148	0.001	CcSEcCtD
Pemetrexed—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000148	0.001	CcSEcCtD
Pemetrexed—Alopecia—Estradiol—osteoporosis	0.000147	0.000999	CcSEcCtD
Pemetrexed—Infection—Conjugated Estrogens—osteoporosis	0.000147	0.000997	CcSEcCtD
Pemetrexed—Diarrhoea—Ibandronate—osteoporosis	0.000147	0.000997	CcSEcCtD
Pemetrexed—GART—Metabolism—GAPDH—osteoporosis	0.000146	0.00137	CbGpPWpGaD
Pemetrexed—Anorexia—Zoledronate—osteoporosis	0.000146	0.000994	CcSEcCtD
Pemetrexed—Decreased appetite—Pamidronate—osteoporosis	0.000146	0.000992	CcSEcCtD
Pemetrexed—Dizziness—Alendronate—osteoporosis	0.000145	0.00099	CcSEcCtD
Pemetrexed—Shock—Conjugated Estrogens—osteoporosis	0.000145	0.000988	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000145	0.000985	CcSEcCtD
Pemetrexed—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000145	0.000984	CcSEcCtD
Pemetrexed—Erythema—Estradiol—osteoporosis	0.000145	0.000984	CcSEcCtD
Pemetrexed—Malnutrition—Estradiol—osteoporosis	0.000145	0.000984	CcSEcCtD
Pemetrexed—Fatigue—Pamidronate—osteoporosis	0.000145	0.000984	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Risedronate—osteoporosis	0.000144	0.000982	CcSEcCtD
Pemetrexed—Urticaria—Ethinyl Estradiol—osteoporosis	0.000144	0.000978	CcSEcCtD
Pemetrexed—Pain—Pamidronate—osteoporosis	0.000143	0.000976	CcSEcCtD
Pemetrexed—Constipation—Pamidronate—osteoporosis	0.000143	0.000976	CcSEcCtD
Pemetrexed—Diarrhoea—Calcitriol—osteoporosis	0.000143	0.000976	CcSEcCtD
Pemetrexed—Skin disorder—Conjugated Estrogens—osteoporosis	0.000143	0.000975	CcSEcCtD
Pemetrexed—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000143	0.000973	CcSEcCtD
Pemetrexed—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000143	0.000973	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—ATIC—osteoporosis	0.000143	0.00134	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PNP—osteoporosis	0.000143	0.00134	CbGpPWpGaD
Pemetrexed—Dizziness—Raloxifene—osteoporosis	0.000143	0.000973	CcSEcCtD
Pemetrexed—GART—Metabolism—RAP1A—osteoporosis	0.000143	0.00133	CbGpPWpGaD
Pemetrexed—Vomiting—Estropipate—osteoporosis	0.000142	0.000966	CcSEcCtD
Pemetrexed—Dysgeusia—Estradiol—osteoporosis	0.000142	0.000964	CcSEcCtD
Pemetrexed—Dizziness—Ibandronate—osteoporosis	0.000142	0.000963	CcSEcCtD
Pemetrexed—Rash—Estropipate—osteoporosis	0.000141	0.000958	CcSEcCtD
Pemetrexed—Dermatitis—Estropipate—osteoporosis	0.000141	0.000957	CcSEcCtD
Pemetrexed—Anorexia—Conjugated Estrogens—osteoporosis	0.000141	0.000957	CcSEcCtD
Pemetrexed—Urticaria—Risedronate—osteoporosis	0.00014	0.000954	CcSEcCtD
Pemetrexed—Vomiting—Alendronate—osteoporosis	0.00014	0.000951	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00014	0.00095	CcSEcCtD
Pemetrexed—Body temperature increased—Risedronate—osteoporosis	0.00014	0.000949	CcSEcCtD
Pemetrexed—Abdominal pain—Risedronate—osteoporosis	0.00014	0.000949	CcSEcCtD
Pemetrexed—Rash—Alendronate—osteoporosis	0.000139	0.000943	CcSEcCtD
Pemetrexed—Dermatitis—Alendronate—osteoporosis	0.000139	0.000943	CcSEcCtD
Pemetrexed—SLC46A1—Disease—LRP5—osteoporosis	0.000138	0.00129	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000138	0.00129	CbGpPWpGaD
Pemetrexed—Vomiting—Raloxifene—osteoporosis	0.000138	0.000936	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Pamidronate—osteoporosis	0.000137	0.000933	CcSEcCtD
Pemetrexed—Dyspnoea—Zoledronate—osteoporosis	0.000137	0.000929	CcSEcCtD
Pemetrexed—Rash—Raloxifene—osteoporosis	0.000136	0.000928	CcSEcCtD
Pemetrexed—Dermatitis—Raloxifene—osteoporosis	0.000136	0.000927	CcSEcCtD
Pemetrexed—Vomiting—Ibandronate—osteoporosis	0.000136	0.000926	CcSEcCtD
Pemetrexed—Rash—Ibandronate—osteoporosis	0.000135	0.000919	CcSEcCtD
Pemetrexed—Dermatitis—Ibandronate—osteoporosis	0.000135	0.000918	CcSEcCtD
Pemetrexed—Dyspepsia—Zoledronate—osteoporosis	0.000135	0.000918	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000134	0.000915	CcSEcCtD
Pemetrexed—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000133	0.000907	CcSEcCtD
Pemetrexed—Vomiting—Calcitriol—osteoporosis	0.000133	0.000907	CcSEcCtD
Pemetrexed—Decreased appetite—Zoledronate—osteoporosis	0.000133	0.000906	CcSEcCtD
Pemetrexed—Nausea—Estropipate—osteoporosis	0.000133	0.000902	CcSEcCtD
Pemetrexed—Abdominal pain—Pamidronate—osteoporosis	0.000133	0.000902	CcSEcCtD
Pemetrexed—Body temperature increased—Pamidronate—osteoporosis	0.000133	0.000902	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000132	0.0009	CcSEcCtD
Pemetrexed—Rash—Calcitriol—osteoporosis	0.000132	0.000899	CcSEcCtD
Pemetrexed—SLC46A1—Disease—LRP6—osteoporosis	0.000132	0.00124	CbGpPWpGaD
Pemetrexed—Fatigue—Zoledronate—osteoporosis	0.000132	0.000899	CcSEcCtD
Pemetrexed—Dermatitis—Calcitriol—osteoporosis	0.000132	0.000898	CcSEcCtD
Pemetrexed—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000132	0.000895	CcSEcCtD
Pemetrexed—Pain—Zoledronate—osteoporosis	0.000131	0.000892	CcSEcCtD
Pemetrexed—Constipation—Zoledronate—osteoporosis	0.000131	0.000892	CcSEcCtD
Pemetrexed—Nausea—Alendronate—osteoporosis	0.000131	0.000889	CcSEcCtD
Pemetrexed—Hypersensitivity—Risedronate—osteoporosis	0.00013	0.000885	CcSEcCtD
Pemetrexed—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00013	0.000884	CcSEcCtD
Pemetrexed—Asthenia—Ethinyl Estradiol—osteoporosis	0.00013	0.000884	CcSEcCtD
Pemetrexed—Syncope—Estradiol—osteoporosis	0.00013	0.000883	CcSEcCtD
Pemetrexed—ATIC—Metabolism—IDH2—osteoporosis	0.000129	0.00121	CbGpPWpGaD
Pemetrexed—Nausea—Raloxifene—osteoporosis	0.000129	0.000874	CcSEcCtD
Pemetrexed—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000128	0.000873	CcSEcCtD
Pemetrexed—Pruritus—Ethinyl Estradiol—osteoporosis	0.000128	0.000871	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000127	0.000867	CcSEcCtD
Pemetrexed—Fatigue—Conjugated Estrogens—osteoporosis	0.000127	0.000865	CcSEcCtD
Pemetrexed—Nausea—Ibandronate—osteoporosis	0.000127	0.000865	CcSEcCtD
Pemetrexed—Loss of consciousness—Estradiol—osteoporosis	0.000127	0.000865	CcSEcCtD
Pemetrexed—SLC46A1—Disease—LTF—osteoporosis	0.000127	0.00119	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RPL24—osteoporosis	0.000127	0.00119	CbGpPWpGaD
Pemetrexed—Asthenia—Risedronate—osteoporosis	0.000127	0.000861	CcSEcCtD
Pemetrexed—Constipation—Conjugated Estrogens—osteoporosis	0.000126	0.000858	CcSEcCtD
Pemetrexed—Pain—Conjugated Estrogens—osteoporosis	0.000126	0.000858	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Zoledronate—osteoporosis	0.000125	0.000853	CcSEcCtD
Pemetrexed—Hypertension—Estradiol—osteoporosis	0.000125	0.00085	CcSEcCtD
Pemetrexed—Pruritus—Risedronate—osteoporosis	0.000125	0.000849	CcSEcCtD
Pemetrexed—Nausea—Calcitriol—osteoporosis	0.000125	0.000847	CcSEcCtD
Pemetrexed—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000124	0.000843	CcSEcCtD
Pemetrexed—Hypersensitivity—Pamidronate—osteoporosis	0.000124	0.000841	CcSEcCtD
Pemetrexed—Myalgia—Estradiol—osteoporosis	0.000123	0.000838	CcSEcCtD
Pemetrexed—Chest pain—Estradiol—osteoporosis	0.000123	0.000838	CcSEcCtD
Pemetrexed—Arthralgia—Estradiol—osteoporosis	0.000123	0.000838	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000122	0.000832	CcSEcCtD
Pemetrexed—Urticaria—Zoledronate—osteoporosis	0.000122	0.000828	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CYP27A1—osteoporosis	0.000122	0.00114	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CA2—osteoporosis	0.000122	0.00114	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—OXCT1—osteoporosis	0.000122	0.00114	CbGpPWpGaD
Pemetrexed—Abdominal pain—Zoledronate—osteoporosis	0.000121	0.000824	CcSEcCtD
Pemetrexed—Body temperature increased—Zoledronate—osteoporosis	0.000121	0.000824	CcSEcCtD
Pemetrexed—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000121	0.0388	CbGdCrCtD
Pemetrexed—Diarrhoea—Risedronate—osteoporosis	0.000121	0.000821	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000121	0.000821	CcSEcCtD
Pemetrexed—Asthenia—Pamidronate—osteoporosis	0.00012	0.000819	CcSEcCtD
Pemetrexed—Dizziness—Ethinyl Estradiol—osteoporosis	0.00012	0.000814	CcSEcCtD
Pemetrexed—Pruritus—Pamidronate—osteoporosis	0.000119	0.000808	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—MGLL—osteoporosis	0.000119	0.00111	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ACP5—osteoporosis	0.000118	0.00111	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Estradiol—osteoporosis	0.000118	0.000803	CcSEcCtD
Pemetrexed—Oedema—Estradiol—osteoporosis	0.000118	0.000803	CcSEcCtD
Pemetrexed—Infection—Estradiol—osteoporosis	0.000117	0.000798	CcSEcCtD
Pemetrexed—Urticaria—Conjugated Estrogens—osteoporosis	0.000117	0.000797	CcSEcCtD
Pemetrexed—Dizziness—Risedronate—osteoporosis	0.000117	0.000794	CcSEcCtD
Pemetrexed—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000117	0.000794	CcSEcCtD
Pemetrexed—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000117	0.000794	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000116	0.00109	CbGpPWpGaD
Pemetrexed—Shock—Estradiol—osteoporosis	0.000116	0.00079	CcSEcCtD
Pemetrexed—Nervous system disorder—Estradiol—osteoporosis	0.000116	0.000788	CcSEcCtD
Pemetrexed—GART—Metabolism—ENO1—osteoporosis	0.000115	0.00108	CbGpPWpGaD
Pemetrexed—Vomiting—Ethinyl Estradiol—osteoporosis	0.000115	0.000783	CcSEcCtD
Pemetrexed—Diarrhoea—Pamidronate—osteoporosis	0.000115	0.000781	CcSEcCtD
Pemetrexed—Skin disorder—Estradiol—osteoporosis	0.000115	0.00078	CcSEcCtD
Pemetrexed—Rash—Ethinyl Estradiol—osteoporosis	0.000114	0.000776	CcSEcCtD
Pemetrexed—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000114	0.000776	CcSEcCtD
Pemetrexed—GART—Metabolism—PSMA5—osteoporosis	0.000114	0.00106	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PSMA2—osteoporosis	0.000114	0.00106	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Zoledronate—osteoporosis	0.000113	0.000768	CcSEcCtD
Pemetrexed—Vomiting—Risedronate—osteoporosis	0.000112	0.000763	CcSEcCtD
Pemetrexed—Rash—Risedronate—osteoporosis	0.000111	0.000757	CcSEcCtD
Pemetrexed—Dermatitis—Risedronate—osteoporosis	0.000111	0.000756	CcSEcCtD
Pemetrexed—Dizziness—Pamidronate—osteoporosis	0.000111	0.000755	CcSEcCtD
Pemetrexed—DCK—Metabolism—PKM—osteoporosis	0.00011	0.00103	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—FDPS—osteoporosis	0.00011	0.00103	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ACP5—osteoporosis	0.00011	0.00103	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—TPI1—osteoporosis	0.00011	0.00103	CbGpPWpGaD
Pemetrexed—Asthenia—Zoledronate—osteoporosis	0.00011	0.000748	CcSEcCtD
Pemetrexed—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000109	0.00074	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TNF—osteoporosis	0.000109	0.00102	CbGpPWpGaD
Pemetrexed—Pruritus—Zoledronate—osteoporosis	0.000108	0.000738	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—MYC—osteoporosis	0.000108	0.00101	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000108	0.000732	CcSEcCtD
Pemetrexed—Nausea—Ethinyl Estradiol—osteoporosis	0.000108	0.000731	CcSEcCtD
Pemetrexed—Vomiting—Pamidronate—osteoporosis	0.000107	0.000726	CcSEcCtD
Pemetrexed—Asthenia—Conjugated Estrogens—osteoporosis	0.000106	0.00072	CcSEcCtD
Pemetrexed—Rash—Pamidronate—osteoporosis	0.000106	0.00072	CcSEcCtD
Pemetrexed—Dermatitis—Pamidronate—osteoporosis	0.000106	0.000719	CcSEcCtD
Pemetrexed—DHFR—Disease—PKM—osteoporosis	0.000106	0.000988	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SOST—osteoporosis	0.000106	0.000988	CbGpPWpGaD
Pemetrexed—Dyspnoea—Estradiol—osteoporosis	0.000105	0.000716	CcSEcCtD
Pemetrexed—Diarrhoea—Zoledronate—osteoporosis	0.000105	0.000713	CcSEcCtD
Pemetrexed—Nausea—Risedronate—osteoporosis	0.000105	0.000713	CcSEcCtD
Pemetrexed—Pruritus—Conjugated Estrogens—osteoporosis	0.000104	0.00071	CcSEcCtD
Pemetrexed—DCK—Metabolism—PGLS—osteoporosis	0.000104	0.000976	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPD2—osteoporosis	0.000104	0.000976	CbGpPWpGaD
Pemetrexed—Dyspepsia—Estradiol—osteoporosis	0.000104	0.000707	CcSEcCtD
Pemetrexed—ATIC—Metabolism—P4HB—osteoporosis	0.000103	0.000968	CbGpPWpGaD
Pemetrexed—Decreased appetite—Estradiol—osteoporosis	0.000103	0.000698	CcSEcCtD
Pemetrexed—SLC46A1—Disease—TPI1—osteoporosis	0.000102	0.000957	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Estradiol—osteoporosis	0.000102	0.000694	CcSEcCtD
Pemetrexed—Fatigue—Estradiol—osteoporosis	0.000102	0.000693	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GAPDH—osteoporosis	0.000102	0.00095	CbGpPWpGaD
Pemetrexed—Dizziness—Zoledronate—osteoporosis	0.000101	0.000689	CcSEcCtD
Pemetrexed—Constipation—Estradiol—osteoporosis	0.000101	0.000687	CcSEcCtD
Pemetrexed—Pain—Estradiol—osteoporosis	0.000101	0.000687	CcSEcCtD
Pemetrexed—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000101	0.000687	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—IDH2—osteoporosis	0.000101	0.000943	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ANTXR2—osteoporosis	0.0001	0.000937	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PGLS—osteoporosis	0.0001	0.000937	CbGpPWpGaD
Pemetrexed—Nausea—Pamidronate—osteoporosis	9.97e-05	0.000678	CcSEcCtD
Pemetrexed—ATIC—Metabolism—RAP1A—osteoporosis	9.89e-05	0.000925	CbGpPWpGaD
Pemetrexed—Dizziness—Conjugated Estrogens—osteoporosis	9.76e-05	0.000664	CcSEcCtD
Pemetrexed—Vomiting—Zoledronate—osteoporosis	9.74e-05	0.000663	CcSEcCtD
Pemetrexed—Rash—Zoledronate—osteoporosis	9.66e-05	0.000657	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Estradiol—osteoporosis	9.66e-05	0.000657	CcSEcCtD
Pemetrexed—Dermatitis—Zoledronate—osteoporosis	9.65e-05	0.000657	CcSEcCtD
Pemetrexed—SLC46A1—Disease—P4HB—osteoporosis	9.62e-05	0.0009	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PNP—osteoporosis	9.55e-05	0.000893	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ATIC—osteoporosis	9.55e-05	0.000893	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP27A1—osteoporosis	9.48e-05	0.000887	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—GAPDH—osteoporosis	9.45e-05	0.000883	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—MYC—osteoporosis	9.39e-05	0.000879	CbGpPWpGaD
Pemetrexed—Vomiting—Conjugated Estrogens—osteoporosis	9.38e-05	0.000638	CcSEcCtD
Pemetrexed—Urticaria—Estradiol—osteoporosis	9.38e-05	0.000638	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	9.36e-05	0.000875	CbGpPWpGaD
Pemetrexed—Abdominal pain—Estradiol—osteoporosis	9.34e-05	0.000635	CcSEcCtD
Pemetrexed—Body temperature increased—Estradiol—osteoporosis	9.34e-05	0.000635	CcSEcCtD
Pemetrexed—Rash—Conjugated Estrogens—osteoporosis	9.31e-05	0.000633	CcSEcCtD
Pemetrexed—Dermatitis—Conjugated Estrogens—osteoporosis	9.3e-05	0.000632	CcSEcCtD
Pemetrexed—GART—Metabolism—CYP19A1—osteoporosis	9.22e-05	0.000862	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ACP5—osteoporosis	9.22e-05	0.000862	CbGpPWpGaD
Pemetrexed—Nausea—Zoledronate—osteoporosis	9.1e-05	0.000619	CcSEcCtD
Pemetrexed—SLC46A1—Disease—NFATC1—osteoporosis	8.97e-05	0.000839	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—DKK1—osteoporosis	8.9e-05	0.000833	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PKM—osteoporosis	8.85e-05	0.000828	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FDPS—osteoporosis	8.85e-05	0.000828	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IL6—osteoporosis	8.77e-05	0.00082	CbGpPWpGaD
Pemetrexed—Nausea—Conjugated Estrogens—osteoporosis	8.77e-05	0.000596	CcSEcCtD
Pemetrexed—Hypersensitivity—Estradiol—osteoporosis	8.7e-05	0.000592	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.69e-05	0.000812	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—WNT1—osteoporosis	8.58e-05	0.000802	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—TPI1—osteoporosis	8.57e-05	0.000802	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PSMA5—osteoporosis	8.57e-05	0.000801	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PSMA2—osteoporosis	8.57e-05	0.000801	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GSN—osteoporosis	8.52e-05	0.000797	CbGpPWpGaD
Pemetrexed—Asthenia—Estradiol—osteoporosis	8.47e-05	0.000576	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—LEP—osteoporosis	8.41e-05	0.000787	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PGLS—osteoporosis	8.39e-05	0.000785	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPD2—osteoporosis	8.39e-05	0.000785	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.37e-05	0.000783	CbGpPWpGaD
Pemetrexed—Pruritus—Estradiol—osteoporosis	8.36e-05	0.000568	CcSEcCtD
Pemetrexed—SLC46A1—Disease—FGA—osteoporosis	8.34e-05	0.00078	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	8.16e-05	0.000764	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CA2—osteoporosis	8.12e-05	0.000759	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—OXCT1—osteoporosis	8.12e-05	0.000759	CbGpPWpGaD
Pemetrexed—Diarrhoea—Estradiol—osteoporosis	8.08e-05	0.00055	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—P4HB—osteoporosis	8.06e-05	0.000754	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ENO1—osteoporosis	7.99e-05	0.000748	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MGLL—osteoporosis	7.91e-05	0.00074	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GAPDH—osteoporosis	7.91e-05	0.00074	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PSMA2—osteoporosis	7.88e-05	0.000737	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PSMA5—osteoporosis	7.88e-05	0.000737	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—MYC—osteoporosis	7.81e-05	0.000731	CbGpPWpGaD
Pemetrexed—Dizziness—Estradiol—osteoporosis	7.81e-05	0.000531	CcSEcCtD
Pemetrexed—TYMS—Metabolism—FDPS—osteoporosis	7.72e-05	0.000722	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PKM—osteoporosis	7.72e-05	0.000722	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—RAP1A—osteoporosis	7.7e-05	0.000721	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PNP—osteoporosis	7.67e-05	0.000718	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ATIC—osteoporosis	7.67e-05	0.000718	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PSMA5—osteoporosis	7.66e-05	0.000716	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PSMA2—osteoporosis	7.66e-05	0.000716	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ADCY5—osteoporosis	7.53e-05	0.000705	CbGpPWpGaD
Pemetrexed—Vomiting—Estradiol—osteoporosis	7.51e-05	0.000511	CcSEcCtD
Pemetrexed—GART—Metabolism—GPX1—osteoporosis	7.51e-05	0.000702	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	7.47e-05	0.000699	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	7.47e-05	0.000699	CbGpPWpGaD
Pemetrexed—Rash—Estradiol—osteoporosis	7.45e-05	0.000507	CcSEcCtD
Pemetrexed—Dermatitis—Estradiol—osteoporosis	7.44e-05	0.000506	CcSEcCtD
Pemetrexed—SLC46A1—Disease—ENO1—osteoporosis	7.44e-05	0.000696	CbGpPWpGaD
Pemetrexed—DHFR—Disease—LRP5—osteoporosis	7.41e-05	0.000693	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PSMA5—osteoporosis	7.33e-05	0.000685	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PSMA2—osteoporosis	7.33e-05	0.000685	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PGLS—osteoporosis	7.32e-05	0.000685	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPD2—osteoporosis	7.32e-05	0.000685	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.24e-05	0.000677	CbGpPWpGaD
Pemetrexed—DHFR—Disease—LRP6—osteoporosis	7.09e-05	0.000663	CbGpPWpGaD
Pemetrexed—Nausea—Estradiol—osteoporosis	7.02e-05	0.000477	CcSEcCtD
Pemetrexed—GART—Metabolism—MTHFR—osteoporosis	6.93e-05	0.000648	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.89e-05	0.000644	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CALCA—osteoporosis	6.83e-05	0.000639	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—MYC—osteoporosis	6.82e-05	0.000638	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPL24—osteoporosis	6.81e-05	0.000637	CbGpPWpGaD
Pemetrexed—DHFR—Disease—LTF—osteoporosis	6.81e-05	0.000637	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—IDH2—osteoporosis	6.73e-05	0.000629	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PNP—osteoporosis	6.69e-05	0.000626	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ATIC—osteoporosis	6.69e-05	0.000626	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PSMA2—osteoporosis	6.68e-05	0.000625	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PSMA5—osteoporosis	6.68e-05	0.000625	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—osteoporosis	6.58e-05	0.000616	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—OXCT1—osteoporosis	6.52e-05	0.00061	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CA2—osteoporosis	6.52e-05	0.00061	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP19A1—osteoporosis	6.39e-05	0.000598	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MGLL—osteoporosis	6.36e-05	0.000595	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP27A1—osteoporosis	6.32e-05	0.000592	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ENO1—osteoporosis	6.23e-05	0.000583	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KL—osteoporosis	6.2e-05	0.00058	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ACP5—osteoporosis	6.15e-05	0.000575	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PSMA2—osteoporosis	6.14e-05	0.000574	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PSMA5—osteoporosis	6.14e-05	0.000574	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ACP5—osteoporosis	5.9e-05	0.000552	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	5.74e-05	0.000537	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TPI1—osteoporosis	5.72e-05	0.000535	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA2—osteoporosis	5.69e-05	0.000532	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—OXCT1—osteoporosis	5.69e-05	0.000532	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MGLL—osteoporosis	5.55e-05	0.000519	CbGpPWpGaD
Pemetrexed—GART—Metabolism—POMC—osteoporosis	5.54e-05	0.000518	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TPI1—osteoporosis	5.49e-05	0.000513	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—IDH2—osteoporosis	5.41e-05	0.000506	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—P4HB—osteoporosis	5.38e-05	0.000503	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GAPDH—osteoporosis	5.28e-05	0.000494	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ADCY5—osteoporosis	5.22e-05	0.000488	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GPX1—osteoporosis	5.2e-05	0.000487	CbGpPWpGaD
Pemetrexed—DHFR—Disease—P4HB—osteoporosis	5.16e-05	0.000483	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—RAP1A—osteoporosis	5.14e-05	0.000481	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP27A1—osteoporosis	5.08e-05	0.000475	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GAPDH—osteoporosis	5.06e-05	0.000474	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP19A1—osteoporosis	4.98e-05	0.000466	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ACP5—osteoporosis	4.94e-05	0.000462	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ADCY5—osteoporosis	4.86e-05	0.000454	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NFATC1—osteoporosis	4.81e-05	0.00045	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—MTHFR—osteoporosis	4.8e-05	0.000449	CbGpPWpGaD
Pemetrexed—DHFR—Disease—DKK1—osteoporosis	4.77e-05	0.000447	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—IDH2—osteoporosis	4.72e-05	0.000441	CbGpPWpGaD
Pemetrexed—DHFR—Disease—WNT1—osteoporosis	4.6e-05	0.00043	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TPI1—osteoporosis	4.6e-05	0.00043	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGA—osteoporosis	4.47e-05	0.000418	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—osteoporosis	4.47e-05	0.000418	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP27A1—osteoporosis	4.43e-05	0.000415	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.35e-05	0.000407	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.34e-05	0.000406	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—P4HB—osteoporosis	4.32e-05	0.000404	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ACP5—osteoporosis	4.31e-05	0.000403	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS2—osteoporosis	4.25e-05	0.000398	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GAPDH—osteoporosis	4.24e-05	0.000397	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ENO1—osteoporosis	4.16e-05	0.000389	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—RAP1A—osteoporosis	4.13e-05	0.000386	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PSMA2—osteoporosis	4.09e-05	0.000383	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PSMA5—osteoporosis	4.09e-05	0.000383	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ADCY5—osteoporosis	4.07e-05	0.000381	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GPX1—osteoporosis	4.05e-05	0.000379	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.05e-05	0.000379	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TPI1—osteoporosis	4.01e-05	0.000375	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ENO1—osteoporosis	3.99e-05	0.000373	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PSMA2—osteoporosis	3.93e-05	0.000368	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PSMA5—osteoporosis	3.93e-05	0.000368	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—POMC—osteoporosis	3.84e-05	0.000359	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—P4HB—osteoporosis	3.77e-05	0.000353	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—osteoporosis	3.74e-05	0.00035	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS1—osteoporosis	3.71e-05	0.000347	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GAPDH—osteoporosis	3.7e-05	0.000346	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CALCA—osteoporosis	3.66e-05	0.000342	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—RAP1A—osteoporosis	3.6e-05	0.000337	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6R—osteoporosis	3.49e-05	0.000326	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO1—osteoporosis	3.34e-05	0.000312	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KL—osteoporosis	3.32e-05	0.000311	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP19A1—osteoporosis	3.32e-05	0.000311	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PSMA2—osteoporosis	3.29e-05	0.000308	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PSMA5—osteoporosis	3.29e-05	0.000308	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—osteoporosis	3.14e-05	0.000294	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POMC—osteoporosis	2.99e-05	0.00028	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO1—osteoporosis	2.91e-05	0.000273	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PSMA2—osteoporosis	2.87e-05	0.000269	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PSMA5—osteoporosis	2.87e-05	0.000269	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ADCY5—osteoporosis	2.71e-05	0.000254	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—osteoporosis	2.7e-05	0.000253	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP19A1—osteoporosis	2.67e-05	0.00025	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ADCY5—osteoporosis	2.6e-05	0.000244	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—osteoporosis	2.5e-05	0.000233	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—osteoporosis	2.41e-05	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—osteoporosis	2.4e-05	0.000224	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP19A1—osteoporosis	2.33e-05	0.000218	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS2—osteoporosis	2.28e-05	0.000213	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADCY5—osteoporosis	2.18e-05	0.000204	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—osteoporosis	2.17e-05	0.000203	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—osteoporosis	2.16e-05	0.000202	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	2.11e-05	0.000197	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—osteoporosis	2.07e-05	0.000193	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—osteoporosis	2.06e-05	0.000193	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—osteoporosis	2.01e-05	0.000188	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—POMC—osteoporosis	2e-05	0.000187	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS1—osteoporosis	1.99e-05	0.000186	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ADCY5—osteoporosis	1.9e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—osteoporosis	1.9e-05	0.000177	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—osteoporosis	1.88e-05	0.000176	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6R—osteoporosis	1.87e-05	0.000175	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—osteoporosis	1.75e-05	0.000164	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POMC—osteoporosis	1.6e-05	0.00015	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—osteoporosis	1.55e-05	0.000145	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POMC—osteoporosis	1.4e-05	0.000131	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—osteoporosis	1.11e-05	0.000104	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—osteoporosis	1.1e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—osteoporosis	8.32e-06	7.79e-05	CbGpPWpGaD
